Middle segmental pancreatectomy: A safe and organ-preserving option for benign and low-grade malignant lesions

Table 1 Matched-pairs analysis of patient characteristics between patients who underwent middle segmental pancreatectomy, pancreaticoduodenectomy or extended distal pancreatectomy

Variable	PD (n = 44)	MSP (n = 36)	EDP (n = 26)	P value
				PD vs MSP	MSP vs EDP
Patient characteristics
Gender (M/F)	16/28	9/27	11/15	NS	NS
Age (yr)	50 ± 14 (range 18-71)	49 ± 15 (range 23-76)	49 ± 12 (range 22-79)	NS	NS
Tumor type
Cyst adenomas	13	16	16	NS	NS
Endocrine	1	3	2
IPMN	7	3	2
SPT	16	10	1
Others	7	4	5
Tumor size (mm)	30.8 ± 9.6	26.5 ± 14	31.3 ± 13.5	NS	NS
Tumor location
Head-neck	23	8	0	NS	NS
Neck	16	10	0
Neck-body	5	9	15
Body	0	9	11
Preoperative DM	5	2	4	NS	NS

MSP: Middle segmental pancreatectomy; PD: Pancreaticoduodenectomy; EPD: Extended distal pancreatectomy; IPMN: Intraductal papillary mucinous neoplasms; SPT: Solid pseudopapillary tumor; DM: Diabetes mellitus; NS: Not significant.